Xtant Medical Holdings Inc (XTNT)
0.7252
+0.03
(+4.74%)
USD |
NYAM |
May 17, 16:00
0.7252
0.00 (0.00%)
After-Hours: 20:00
Xtant Medical Holdings Research and Development Expense (Annual): 1.336M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.336M |
| December 31, 2022 | 0.915M |
| December 31, 2021 | 0.87M |
| December 31, 2020 | 0.657M |
| December 31, 2019 | 0.932M |
| December 31, 2018 | 1.702M |
| Date | Value |
|---|---|
| December 31, 2017 | 2.441M |
| December 31, 2016 | 3.411M |
| December 31, 2015 | 2.546M |
| December 31, 2014 | 1.443M |
| December 31, 2013 | 0.5724M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
0.657M
Minimum
2020
1.336M
Maximum
2023
0.942M
Average
0.915M
Median
2022
Research and Development Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.31M |
| Retractable Technologies Inc | 0.5812M |
| InfuSystems Holdings Inc | -- |
| Asensus Surgical Inc | 37.02M |
| Catheter Precision Inc | 0.475M |